V1ta34 Stock Fundamentals
V1TA34 Stock | BRL 185.44 0.00 0.00% |
V1TA34 fundamentals help investors to digest information that contributes to V1TA34's financial success or failures. It also enables traders to predict the movement of V1TA34 Stock. The fundamental analysis module provides a way to measure V1TA34's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to V1TA34 stock.
V1TA34 |
V1TA34 Company Return On Equity Analysis
V1TA34's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current V1TA34 Return On Equity | 1.52 |
Most of V1TA34's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, V1TA34 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, V1TA34 has a Return On Equity of 1.52. This is 211.76% lower than that of the Real Estate sector and significantly higher than that of the REIT—Healthcare Facilities industry. The return on equity for all Brazil stocks is notably lower than that of the firm.
V1TA34 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining V1TA34's current stock value. Our valuation model uses many indicators to compare V1TA34 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across V1TA34 competition to find correlations between indicators driving V1TA34's intrinsic value. More Info.V1TA34 is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.91 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for V1TA34 is roughly 1.10 . Comparative valuation analysis is a catch-all model that can be used if you cannot value V1TA34 by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for V1TA34's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.V1TA34 Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses V1TA34's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of V1TA34 could also be used in its relative valuation, which is a method of valuing V1TA34 by comparing valuation metrics of similar companies.V1TA34 is currently under evaluation in return on equity category among its peers.
V1TA34 Fundamentals
Return On Equity | 1.52 | |||
Return On Asset | 1.38 | |||
Profit Margin | 4.13 % | |||
Operating Margin | 14.38 % | |||
Current Valuation | 69.14 B | |||
Shares Outstanding | 750.11 M | |||
Price To Earning | 23.88 X | |||
Price To Book | 5.59 X | |||
Price To Sales | 30.57 X | |||
Revenue | 3.69 B | |||
Gross Profit | 1.84 B | |||
EBITDA | 1.43 B | |||
Net Income | 152.38 M | |||
Cash And Equivalents | 233.84 M | |||
Cash Per Share | 0.62 X | |||
Total Debt | 11.97 B | |||
Debt To Equity | 1.17 % | |||
Current Ratio | 0.54 X | |||
Book Value Per Share | 27.17 X | |||
Cash Flow From Operations | 1.26 B | |||
Earnings Per Share | 6.37 X | |||
Number Of Employees | 448 | |||
Beta | 1.29 | |||
Market Capitalization | 112.82 B | |||
Z Score | 5.4 | |||
Last Dividend Paid | 4.78 |
About V1TA34 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze V1TA34's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of V1TA34 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of V1TA34 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Ventas, an SP 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties. VENTAS INC operates under REITHealthcare Facilities classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 448 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in V1TA34 Stock
V1TA34 financial ratios help investors to determine whether V1TA34 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in V1TA34 with respect to the benefits of owning V1TA34 security.